Six Innovative Startups Redefining Aging
The Longevity Revolution: Six Biotech Startups Transforming How We Age Armed with cutting-edge biological science, advanced computational tools, and deep-pocketed investors, a new wave of biotech startups is targeting what…
FDA Moves to Update Label of Lilly’s Alzheimer’s Drug to Curb Safety Issues
FDA Approves Label Update for Lilly’s Alzheimer’s Drug Kisunla in Bid to Enhance Safety and Broaden Use The U.S. Food and Drug Administration (FDA) has approved a significant label update…
Trump Announces Potential 200% Tariffs on Drug Imports, Offers One-Year Transition
Trump Floats 200% Tariffs on Pharma Imports, Offers Industry One-Year Grace Period In a move that could significantly reshape the pharmaceutical supply chain and global drug trade, President Donald Trump…
Supreme Court Lifts Ban on RFK Jr.’s Health Department Funding Cuts
Supreme Court Halts Injunction, Allowing RFK Jr.’s HHS Workforce Cuts to Move Forward The U.S. Supreme Court on Tuesday issued a stay that permits the Trump administration to proceed with…
Merck Expands Respiratory Portfolio With $10B Verona Acquisition
Merck Bolsters Respiratory Portfolio With $10B Verona Acquisition Ahead of Keytruda Patent Cliff In the second-largest biopharma acquisition of 2025, Merck is acquiring Verona Pharma for $10 billion, a strategic…
AstraZeneca Expands Gene Therapy Pipeline with JCR Deal Worth Up to $825M
AstraZeneca’s Alexion Taps JCR Pharmaceuticals for Gene Therapy Capsids in Deal Worth Up to $825M AstraZeneca’s rare disease unit, Alexion, is deepening its partnership with Japan-based JCR Pharmaceuticals through a…
Nuclidium Secures $99M Series B to Develop Copper-Based Radiopharma Technology
Nuclidium Secures $99M Series B to Advance Copper-Based Radiopharma Platform Swiss biotech Nuclidium has raised approximately $99 million in a Series B funding round to accelerate the development of its…
Merck to Acquire Verona Pharma, Adding Ohtuvayre to Bolster COPD Portfolio
Merck to Acquire Verona Pharma in $10 Billion Deal, Adding Ohtuvayre® to Strengthen Respiratory Portfolio and Expand Long-Term Growth in COPD Market Merck & Co., known as MSD outside the…
Lilly’s Kisunla Gets FDA Nod for Updated Label and Dosing in Early Alzheimer’s
FDA Greenlights Label Update and Revised Dosing Schedule for Lilly’s Kisunla (donanemab‑azbt) in Early Symptomatic Alzheimer’s Eli Lilly and Company today announced that the U.S. Food and Drug Administration (FDA)…
ICON Team Earns Recognition for Leadership and Sustainable Innovation
ICON Celebrated for Clinical Research Leadership, Innovation, and Sustainability in 2025 a global leader in healthcare intelligence and clinical research, has received widespread industry recognition during the first half of…
Glass Lewis Backs Sinovac’s Current Board
Glass Lewis Endorses Sinovac’s Current Board, Urges Shareholders to Reject Former Directors’ Takeover Attempt Sinovac Biotech Ltd., a leading Chinese biopharmaceutical company, announced today that Glass Lewis, a top independent…
ISS Recommends Sinovac Shareholders Support Current Board
ISS and Glass Lewis Endorse Sinovac’s Current Board Ahead of Crucial Shareholder Vote Sinovac Biotech Ltd. a leading Chinese biopharmaceutical company, announced that Institutional Shareholder Services Inc. (ISS), one of…